A Phase 1, Randomised, Open Label, Two Sequence, Two Treatment, Two Way Crossover Study to Estimate the Steady-state Effect of Erythromycin on the Single Dose Pharmacokinetics of Ph-797804 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2012
At a glance
- Drugs Erythromycin; PH 797804
- Indications Bacterial infections; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Pfizer
- 16 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.